Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)

Market Cap	95.16B
Revenue (ttm)	201.59B
Net Income (ttm)	10.88B
Shares Out	14.04M
EPS (ttm)	775.02
PE Ratio	8.75
Forward PE	n/a
Dividend	100.00 (1.47%)
Ex-Dividend Date	Dec 29, 2025

Volume	8,995
Average Volume	20,305
Open	6,790.00
Previous Close	6,780.00
Day's Range	6,670.00 - 6,790.00
52-Week Range	6,220.00 - 8,810.00
Beta	0.34
RSI	48.33
Earnings Date	Dec 2, 2025

About Daehan Nupharm

Daehan Nupharm Co.,Ltd. manufactures and sells pharmaceuticals and veterinary products in South Korea and internationally. It offers pharmaceuticals drugs for cardiovascular, endocrine system, neuropsychiatric, gastrointestinal, respiratory system, antipyretic, analgesic, anti-inflammatory, anti-infective, musculoskeletal, osteoporosis, anti-cancer, urogenital system, antifungal, antiviral, hormones, dermatologic, central nervous system, anticonvulsive, amino acid, anesthetic, antiobesity, and others; vitamins; and inorganic products. The compa...

• Industry: Pharmaceutical Preparations
• Founded: 1984
• Employees: 228
• Stock Exchange: KOSDAQ
• Ticker Symbol: 054670

Financial Performance

In 2024, Daehan Nupharm's revenue was 202.19 billion, a decrease of -1.00% compared to the previous year's 204.22 billion. Earnings were 15.47 billion, an increase of 23.33%.